在死细胞类细胞死亡过程中,介质素-1α的释放会产生由髓质驱动的免疫抑制,从而限制抗瘤免疫力
Kay Hänggi1, Jie Li2, Achintyan Gangadharan2
1Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.
Cancer cell
|November 22, 2024
概括
在乳腺瘤中诱导亡意外地抑制了免疫反应并促进了生长. 向释放的互白素-1α (IL-1α) 逆转了这种情况,增强了抗癌免疫力,改善了治疗结果.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 细胞死亡的编程形式 - - 亡 (necroptosis) 被提议用于增强抗瘤免疫力.
- 研究了亡媒介RIPK3和MLKL在癌症中的作用.
- 研究了诱导亡的潜力,作为一种癌症治疗方法.
研究的目的:
- 阐明死细胞灭绝影响癌症免疫激活的机制.
- 确定RIPK3和MLKL对于瘤进展的必要性.
- 为了研究诱导死细胞灭绝对瘤微环境和治疗疗效的影响.
主要方法:
- 使用了乳腺和肺癌的遗传模型和植入性瘤模型.
- 在已建立的瘤中诱导了亡.
- 评估了互白素-1α (IL-1α) 在调解死诱导的免疫抑制中的作用.
- 在临床前模型中评估了涉及IL-1α中和,paclitaxel和PD-1阻断的治疗策略.
主要成果:
- 在测试模型中,发现RIPK3和MLKL对于瘤生长是不可缺少的.
- 诱导性亡产生了骨髓抑制的微环境,抑制T细胞功能,促进瘤生长.
- 死亡细胞释放的核警报蛋白IL-1α被确定为这种免疫抑制的关键媒介.
- 向IL-1α降低了骨髓衍生的抑制细胞活性,增强了CD8+ T细胞的招募和功能,并改善了对化疗和免疫治疗的反应.
结论:
- 在已建立的瘤中诱导死亡瘤可以通过IL-1α释放来矛盾地促进免疫抑制性瘤微环境.
- 中和IL-1α是一种有前途的策略,可以克服癌症中的化疗和免疫抵抗.
- 较低的IL1A表达与有利的患者结果相关,特别是在接受化疗的患者中,这表明IL-1α是潜在的治疗标和生物标志物.
关键词:
癌症 癌症 癌症 癌症 癌症化疗 化疗是一种化学疗法.免疫性细胞死亡 免疫性细胞死亡免疫抑制是一种免疫抑制.互白素-1-1的使用情况.巨细胞是什么?巨细胞是什么?尸体亡 (necroptosis) 是一种致死症.一种类似死细胞的细胞死亡.中性粒细胞中性粒细胞.更多相关视频
09:18Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
8.6K
07:49Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model
Published on: April 13, 2015
20.1K
相关概念视频
T Cell Types and Functions
954
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
954
Cytotoxic T Cells-mediated Immune Response
849
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
849
Cells of the Innate Immune Response
1.5K
The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
1.5K
The Extrinsic Apoptotic Pathway
6.3K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.3K
Tumor Immunotherapy
480
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
480
Phagocytosis of Apoptotic Cells
3.7K
Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or immature dendritic cells. Non-professional phagocytes such as epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes.
Normal cells contain receptors that prevent them from being recognized...
Normal cells contain receptors that prevent them from being recognized...
3.7K
